RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition()()

Por Dinglin, Xiaoxiao, Ding, Lin, Li, Qingjian, Liu, Yuanbin, Zhang, Jiexia, Yao, Herui
Publicado no Transl Oncol (2017)

Effect of erlotinib plus bevacizumab on brain metastases in patients with non-small cell lung cancer

Por Chikaishi, Yasuhiro, Kanayama, Masatoshi, Taira, Akihiro, Nabe, Yusuke, Shinohara, Shinji, Kuwata, Taiji, Takenaka, Masaru, Oka, Soichi, Hirai, Ayako, Kuroda, Koji, Imanishi, Naoko, Ichiki, Yoshinobu, Tanaka, Fumihiro
Publicado no Ann Transl Med (2018)

P40. Applying digital tomosynthesis (DTS) to diagnose lung cancer and follow up patients

Por Szondy, Klara, Horvath, Akos, Sutto, Zoltan, Kis, Adrian, Horvath, Gabor, Losonczy, Gyorgy
Publicado no Transl Lung Cancer Res (2014)

P29. Oral topotecan in small cell lung cancer: treatment related side effects

Por Popovic, Filip, Samarzija, Miroslav, Kukulj, Suzana, Redzepi, Gzim, Roglic, Mihovil, Mursic, Davorka, Cucevic, Branka, Plestina, Sanja, Jakopovic, Marko
Publicado no Transl Lung Cancer Res (2014)

Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells

Por Kim, Hyo-Jin, Hwang, Ki-Eun, Park, Do-Sim, Oh, Seon-Hee, Jun, Hong Young, Yoon, Kwon-Ha, Jeong, Eun-Taik, Kim, Hak-Ryul, Kim, Young-Suk
Publicado no J Transl Med (2017)

Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression

Por Li, Xiao-Lei, Jia, Lan-Ling, Shi, Mu-Mu, Li, Xin, Li, Zhong-Hua, Li, Hui-Feng, Wang, En-Hua, Jia, Xin-Shan
Publicado em 2013

Prognostic factors for long term survival in patients with advanced non-small cell lung cancer

Por Moumtzi, Despoina, Lampaki, Sofia, Zarogoulidis, Paul, Porpodis, Konstantinos, Lagoudi, Kalliopi, Hohenforst-Schmidt, Wolfgang, Pataka, Athanasia, Tsiouda, Theodora, Zissimopoulos, Athanasios, Lazaridis, George, Karavasilis, Vasilis, Timotheadou, Helen, Barbetakis, Nikolaos, Pavlidis, Pavlos, Kontakiotis, Theodoros, Zarogoulidis, Konstantinos
Publicado no Ann Transl Med (2016)

Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines

Por De Leyn, Paul, Dooms, Christophe, Kuzdzal, Jaroslaw, Lardinois, Didier, Passlick, Bernward, Rami-Porta, Ramon, Turna, Akif, Van Schil, Paul, Venuta, Frederico, Waller, David, Weder, Walter, Zielinski, Marcin
Publicado no Transl Lung Cancer Res (2014)

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer...

Por Carus, Andreas, Gurney, Howard, Gebski, Val, Harnett, Paul, Hui, Rina, Kefford, Richard, Wilcken, Nicholas, Ladekarl, Morten, von der Maase, Hans, Donskov, Frede
Publicado em 2013

Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer: a systematic review and meta-analysis

Por Zhan, Ping, Zhu, Qing-Qing, Miu, Ying-Ying, Liu, Ya-Fang, Wang, Xiao-Xia, Zhou, Ze-Jun, Jin, Jia-Jia, Li, Qian, Sasada, Shinji, Izumo, Takehiro, Tu, Chih-Yen, Cheng, Wen-Chien, Evison, Matthew, Lv, Tang-Feng, Song, Yong
Publicado no Transl Lung Cancer Res (2017)

Role of PET/CT for precision medicine in lung cancer: perspective of the Society of Nuclear Medicine and Molecular Imaging

Por Greenspan, Bennett S.
Publicado no Transl Lung Cancer Res (2017)

Anti-vascular endothelial growth factor therapies at the crossroads: linifanib for non-small cell lung cancer

Por Horinouchi, Hidehito
Publicado no Transl Lung Cancer Res (2016)

Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer

Por Zhang, Liwen, Chen, Bojiang, Liu, Xia, Song, Jiangdian, Fang, Mengjie, Hu, Chaoen, Dong, Di, Li, Weimin, Tian, Jie
Publicado no Transl Oncol (2017)

Moving molecularly directed therapies to the first-line in ALK-positive lung cancer: crizotinib is just the beginning

Por Klempner, Samuel J., Raufi, Alexander, Ou, Sai-Hong Ignatius
Publicado no Transl Lung Cancer Res (2015)

Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancer

Por Chen, Kuan-Bing, Xuan, Ying, Shi, Wen-Jun, Chi, Feng, Xing, Rui, Zeng, Yue-Can
Publicado no Am J Transl Res (2016)

CHRNA3 rs1051730 polymorphism and lung cancer susceptibility in Asian population: a meta-analysis

Por Zhan, Ping, Song, Yong
Publicado no Transl Lung Cancer Res (2015)

Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?

Por Lo Russo, Giuseppe, Proto, Claudia, Garassino, Marina Chiara
Publicado no Transl Lung Cancer Res (2016)

Resolution of atelectasis during radiochemotherapy of lung cancer with serious implications for further treatment. A case report

Por Braun, Lore Helene, Welz, Stefan, Viehrig, Marén, Heinzelmann, Frank, Zips, Daniel, Gani, Cihan
Publicado no Clin Transl Radiat Oncol (2017)

CYP1A2 rs2069514 polymorphism and lung cancer susceptibility: a meta-analysis

Por Shao, Wenlong, He, Jianxing
Publicado no Ann Transl Med (2015)

Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients

Por Lee, Gina, Gardner, Brian K, Elashoff, David A, Purcell, Colleen M, Sandha, Harpavan S, Mao, Jenny T, Krysan, Kostyantyn, Lee, Jay M, Dubinett, Steven M
Publicado em 2011